CASE REPORT article
Front. Virtual Real.
Sec. Virtual Reality in Medicine
Volume 6 - 2025 | doi: 10.3389/frvir.2025.1595694
Case report: Improvement of diplopia due to severe internuclear ophthalmoplegia by 4-aminopyridine documented using a novel virtual reality based oculography headset
Provisionally accepted- 1Ruhr University Bochum, Bochum, Germany
- 2St Josef Hospital, Bochum, North Rhine-Westphalia, Germany
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Internuclear ophthalmoplegia (INO) is an eye movement disorder that occurs in about one third of people with multiple sclerosis (MS). We used a novel, head-mounted, virtual reality (VR) based oculography device (PRET TM , machineMD AG, Switzerland), to objectively measure oculomotor symptoms reported by a patient with MS to aid in clinical diagnosis confirmation of INO. The patient's symptoms, primarily diplopia, were managed successfully with 4-aminopyridine. The VRbased eye-tracking tool documented the subjective improvement in oculomotor function tracking treatment effects.
Keywords: Internuclear ophthalmoplegia, Multiple Sclerosis, VR-based oculography, 4aminopyridine, Diplopia
Received: 18 Mar 2025; Accepted: 12 Jun 2025.
Copyright: © 2025 Reuter, Luerweg, Schneider, Klimas, Motte, Gold and Salmen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Emilie Sophie Reuter, Ruhr University Bochum, Bochum, Germany
Anke Salmen, Ruhr University Bochum, Bochum, Germany
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.